Atropine / അട്രോപിൻ
Atropine or atropine sulfate carries FDA indications for anti-sialagogue/anti-vagal effect, organophosphate/muscarinic poisoning, and bradycardia.
Atropine acts as a competitive, reversible antagonist of muscarinic receptors: an anticholinergic drug.
This activity outlines the indications, mechanism of action, safe administration, adverse effects, contraindications, toxicology, and monitoring of atropine.
